Literature DB >> 34346057

Prescribing of direct-acting antiviral therapy by general practitioners for people with hepatitis C in an unrestricted treatment program.

Fergus Stafford1, Gregory J Dore1, Shawn Clackett1,2, Marianne Martinello1, Gail V Matthews1, Jason Grebely1, Anne C Balcomb3, Behzad Hajarizadeh1.   

Abstract

Entities:  

Keywords:  General practice; Hepatitis; Hepatitis C; Treatment outcome; viral

Year:  2021        PMID： 34346057     DOI： 10.5694/mja2.51204

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  5 in total

1.  Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study.

Authors:  Mohammad Tasavon Gholamhoseini; Heidar Sharafi; Helena Hl Borba; Seyed Moayed Alavian; Asma Sabermahani; Behzad Hajarizadeh
Journal:  BMJ Open       Date:  2022-06-08       Impact factor: 3.006

Review 2.  Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients.

Authors:  Bridget Draper; Win Lei Yee; Alisa Pedrana; Khin Pyone Kyi; Huma Qureshi; Hla Htay; Win Naing; Alexander J Thompson; Margaret Hellard; Jessica Howell
Journal:  Lancet Reg Health West Pac       Date:  2022-01-01

3.  Developing a primary care-initiated hepatitis C treatment pathway in Scotland: a qualitative study.

Authors:  David Whiteley; Elizabeth M Speakman; Lawrie Elliott; Helen Jarvis; Katherine Davidson; Michael Quinn; Paul Flowers
Journal:  Br J Gen Pract       Date:  2022-03-21       Impact factor: 6.302

4.  Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia.

Authors:  Mohammad T Yousafzai; Maryam Alavi; Heather Valerio; Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Journal:  Viruses       Date:  2022-07-08       Impact factor: 5.818

5.  Retreatment for hepatitis C virus direct acting antiviral therapy virological failure in primary and tertiary settings: the REACH-C cohort.

Authors:  Joanne M Carson; Behzad Hajarizadeh; Josh Hanson; James O'Beirne; David Iser; Phillip Read; Anne Balcomb; Jane Davies; Joseph S Doyle; Jasmine Yee; Marianne Martinello; Philippa Marks; Gail V Matthews; Gregory J Dore
Journal:  J Viral Hepat       Date:  2022-05-18       Impact factor: 3.517
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.